Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of the US Definitions for Coronavirus Disease 2019 Community Risk Levels

Clinical Infectious Diseases(2022)10.1093/cid/ciac922Source: DataRank Database

Evaluation of the US Definitions for Coronavirus Disease 2019 Community Risk Levels is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: hybridTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Alyssa S. Parpia ORCID,Nathan C. Lo ORCID,Martial L. Ndeffo-Mbah ORCID,Sina Mokhtar ORCID

Live enrichment

PubMed:36433715 PMC:PMC10110267 OpenAlex:https://openalex.org/W4310010621

National Science Foundation

Grant: DEB 2028632

(NIH)

Grant: DP2 AI170485

NIAID NIH HHS

Grant: L30 AI171975

National Institutes of Health

Grant: 1DP2AI170485-01

Real-time predictive modeling for public health departments to control infectious diseases

National Science Foundation

Grant: 2028632

RAPID: Collaborative Research: Optimizing non-pharmaceutical and pharmaceutical interventions for controlling COVID-19 at the community-level

University of Toronto

National Institutes of Health

Texas A&M University

FWCI

0.00

Citation Percentile

0.1%

hybridLicense: cc-by-nc-nd

journalhttps://academic.oup.com/cid/article-pdf/76/8/1496/50001364/ciac922.pdf

publisherhttps://academic.oup.com/cid/article-pdf/76/8/1496/50001364/ciac922.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac922/47948840/ciac922.pdf

journalhttps://doi.org/10.1093/cid/ciac922

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36433715

Fields of Study

COVID-19 epidemiological studiesCOVID-19 and healthcare impactsHealth disparities and outcomes03 medical and health sciences0302 clinical medicineUnited StatesHumansCOVID-19SARS-CoV-2Public HealthCenters for Disease Control and Prevention, U.S.

MeSH Terms

COVID-19SARS-CoV-2Centers for Disease Control and Prevention, U.S.HumansPublic HealthUnited States

Keywords

Metric (unit)Coronavirus disease 2019 (COVID-19)MedicinePublic healthDisease controlDiseaseCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakBetacoronavirusEnvironmental healthCompromisePandemicVirologyInfectious disease (medical specialty)OutbreakOperations managementInternal medicineConsistencyCovid-19Community Risk LevelSARS-CoV-2Brief ReportHumansCenters for Disease Control and Prevention, U.S.United States

Sustainable Development Goals

SDG 0: Peace, Justice and strong institutions